Brevan Howard Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.51M | Sell |
6,682
-657
| -9% | -$345K | 0.02% | 442 |
|
|
2025
Q1 | $4.65M | Sell |
7,339
-351
| -5% | -$223K | 0.04% | 116 |
|
|
2024
Q4 | $5.48M | Buy |
7,690
+4,506
| +142% | +$3.21M | 0.04% | 111 |
|
|
2024
Q3 | $3.35M | Buy |
+3,184
| New | +$3.35M | 0.02% | 128 |
|
|
2024
Q2 | – | Sell |
-3,106
| Closed | -$2.99M | – | 1294 |
|
|
2024
Q1 | $2.99M | Buy |
3,106
+1,943
| +167% | +$1.87M | 0.03% | 66 |
|
|
2023
Q4 | $1.02M | Buy |
+1,163
| New | +$1.02M | 0.01% | 186 |
|